at some point, this will backfire mightily on them. there
at some point, this will backfire mightily on them. there are 2 reasons to be adding shares consistently right now:
1. short-term / trade: the massive short interest is like a giant pile of dry kindling, that will absolutely explode on any good news / positive momentum. it is inevitable. and there are too many potential catalysts in the works right now.
2. long-term / hold: at 800MM, our market cap has shrunk to such a tiny % of the potential value (long-term) that it has become insanely cheap.
personally, i am buying for both reasons (well, not that i'll sell on a potential rebound). i try not to judge and don't judge tactical traders (except for the POS traders who bash the co. to drive the price down, and then change their tune to buy - pretty despicable) - i just happen to be a buy and hold because i believe this asset will be worth a fortune one day.
but my point is this - as hard as it is to be positive here after a year of difficult declines - it is precisely the time to be maximum positive. too many amazing things lined up, and a price that is dirt cheap.
my two cents - i'll be buying again next week. and no, it hasn't worked recently, and yes, i've bitched from time to time about getting my ass kicked over the past year. but i'm highly confident in what we own - it's just a matter of time. if you can hold this and keep your wits, you'll make 20-50X from here.
21
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...
Continue Reading
Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...
Continue Reading
Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...
Continue Reading
Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...
Continue Reading
Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...
Continue Reading